Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Contentious grain bill put directly to plenary meeting for vote

    Contentious grain bill put directly to plenary meeting for vote
  2. 2

    Yoon's approval rating plunges to all-time low

    Yoon's approval rating plunges to all-time low
  3. 3

    Will tug-of-war between doctors, government end soon?

    Will tug-of-war between doctors, government end soon?
  4. 4

    Climate impacts set to cut 2050 global GDP by nearly a fifth

    Climate impacts set to cut 2050 global GDP by nearly a fifth
  5. 5

    Trilateral talks acknowledge ‘serious’ slumps of won, yen

    Trilateral talks acknowledge ‘serious’ slumps of won, yen
  1. 6

    [Graphic News] More Koreans say they plan long-distance trips this year

    [Graphic News] More Koreans say they plan long-distance trips this year
  2. 7

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
  3. 8

    North Korea removes streetlights along cross-border roads with South

    North Korea removes streetlights along cross-border roads with South
  4. 9

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
  5. 10

    Farming households dip below 1m for first time in 2023

    Farming households dip below 1m for first time in 2023
지나쌤

Financial watchdog finds accounting violation at Samsung BioLogics

By Yonhap

Published : May 1, 2018 - 21:19

    • Link copied

 South Korea’s financial watchdog said Tuesday that Samsung Group‘s bio unit has violated accounting rules, and corrective measures and punishment may be taken depending on the final outcome.

Since March last year, the Financial Supervisory Service (FSS) has been conducting a special audit on Samsung BioLogics Co., a biopharmaceutical unit of Samsung Group, over alleged accounting irregularities.

The bio firm’s accounting flaw boils down to whether there were any irregularities over a dramatic business turnaround in 2015.

Samsung BioLogics headquarters in Songdo, Incheon (Yonhap) Samsung BioLogics headquarters in Songdo, Incheon (Yonhap)

Samsung BioLogics, listed on the local stock market in November 2016, reported a net profit of a whopping 1.9 trillion won in 2015, shifting from a loss in the previous four years.

In 2015, Samsung BioLogics adopted the mark-to-market accounting scheme for Samsung Bioepis, a joint venture with U.S.-based pharmaceutical company Biogen Inc., which boosted its equity gains from the JV.

Previously, Samsung BioLogics adopted a face-value accounting method for its stake in the JV.

Mark-to-market is an accounting method of valuing securities or financial instruments that a company holds at the current market prices. (Yonhap)

More from Headlines